Veterinary pharmaceutical company Rodec Pharma has submitted draft papers to the Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO).
The proposed IPO will be entirely an offer for sale (OFS) of 56,50,000 equity shares by promoter Mukesh Kumar Gupta, with no fresh issue component. As a result, the company will not receive any proceeds from the issue, and the entire amount raised will accrue to the selling shareholder.
Khambatta Securities has been appointed as the book-running lead manager for the issue, while Bigshare Services will act as the registrar. The company’s shares are proposed to be listed on both the National Stock Exchange (NSE) and the BSE.
Rodec Pharma is engaged in the manufacture of animal feed supplements and the marketing of veterinary pharmaceutical products, catering to the healthcare and nutritional needs of livestock. The company follows an integrated business model encompassing production, distribution, and marketing, enabling it to efficiently reach end-users and strengthen its footprint across various regions.
The company’s distribution network spans several states, including Maharashtra, Uttarakhand, Uttar Pradesh, Haryana, Punjab, Gujarat, Madhya Pradesh, Telangana, Chhattisgarh, Assam, Bihar, Rajasthan, Jharkhand, West Bengal, and Himachal Pradesh.
Rodec Pharma reported a 20.73% rise in revenue from operations to ₹108.19 crore for the year ended March 2025, compared with ₹89.61 crore in the previous fiscal year. Profit after tax surged 65.45% to ₹18.25 crore in FY25, up from ₹11.03 crore a year earlier.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 13, 2026, 9:12 AM IST
Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
